Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific ImmunoDiagnostics by Quarter
ImmunoDiagnostics (Phadia Allergy & Autoimmune Diagnostics) ($M)
Thermo Fisher Scientific ImmunoDiagnostics: $248M in Q2 2026, up 6.0% from a year earlier. That is the highest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
“|| ImmunoDiagnostics | 248 | 234 | 478 | 451”
Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Reported in SEC 10-K / 10-Q Note 6 (Revenue by Business).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | ImmunoDiagnostics (Phadia Allergy & Autoimmune Diagnostics) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 248 | +6.0% | SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 230 | +6.0% | SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 231 | +7.4% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 230 | +8.5% | SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗ |
| Q2 2025 | Jun 30, 2025 | 234 | +3.5% | SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗ |
| Q1 2025 | Mar 31, 2025 | 217 | +2.4% | SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 215 | – | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 212 | – | SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 226 | – | SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗ |
| Q1 2024 | Mar 31, 2024 | 212 | – | SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific ImmunoDiagnostics ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-biz-immunodiagnostics
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.